Trudie Lang on May 3, 2011
The KEMRI-Wellcome Trust Research Programme is internationally renowned for its work in tackling malaria and other infectious diseases. The programme has a strong record of conducting high-quality clinical trials to find new treatments and vaccines that are urgently needed to meet some of the major health challenges in developing countries.
To address the need for high-quality trials, the programme established a dedicated Clinical Trials Facility (CTF) to oversee the design, strategy, coordination and governance of high-quality phase I, II, III and IV clinical trials across East Africa. The facility and its processes have been designed to maximise opportunities for learning and training with the aim of developing a cadre of highly skilled and experienced African trialists from all disciplines.
We are looking for a new Head of the Clinical Trials Facility who will ensure that the facility’s strategy enables the programme to fulfil its potential as a leader in supporting world-class clinical trials in Africa. The postholder will lead on leveraging external funding sources to support the further development of the activities at the facility and will have overall responsibility for budget management (the current three-year budget is approximately $7.8 million with a portfolio of 6-8 grants). The successful candidate will have management responsibility for around 100 staff in the facility and will be responsible for capacity building activities and professional development within the facility’s operations. The postholder will also participate in the key management groups at the programme as well as advise the Scientific Director on strategic issues related to clinical trials.
To excel in this position, you will have a PhD or equivalent in a field related to health research and have significant experience in the conduct of clinical trials. Strong diplomatic skills and proven oral and written presentation skills are essential. Experience of conducting clinical trials in Africa is desirable. The post is available for three years in the first instance.
Applicants for this vacancy are to be made online. To apply for this role and for further details, including a job description and person specification, please click on the link below:
Only applications received before 12.00 midday on Friday 20 May 2011 will be considered.
The Editorial Team on Oct. 25, 2011
An international partnership is looking for potential collaborators for planned phase II and III clinical trials. If you would like to register the possible interest of your clinical trial site then please let them know
The Editorial Team on Dec. 15, 2011
This article, provided here in full, discusses phase 0 and 1 clinical trials in humans in LMC countries.
An international TB Partnership looking for Trial Sites for upcoming phase I and II trials. The CPTR Initiative aims to ...
Hi Everyone, Firstly, I would like to quickly introduce myself. I have recently started working for the Global Health Clinical ...
I have just completed the Short Course in Clinical Trials at the London School of Hygiene and Tropical Medicine. I ...
Today we have launched the pilot for the Global Health Clinical Trials website. We aim for this to be a ...
Development of an online resource for recruitment research in clinical trials to organise and map current literatureby Anna Kearney, Nicola Harman, Anna Rosala-Hallas, Claire Beecher, Jane Blazeby, Peter Bower, Mike Clarke, William Cragg, Sinead Dune, Heidi Gardner, Patricia Healy, Lisa Maguire, Nicola Mills, Leila Rooshenas, Ceri Rowlands, Shaun Treweek, Akke Vellinga, Paula Williamson, Carrol Gamble
Transparency in the conduct and reporting of clinical trials is supported by the guidance produced on the content of clinical trial protocols and reporting standards for clinical trials. While the principle features of the statistical analysis are required within this guidance it is generally accepted that a separate Statistical Analysis Plan is also developed as the level of detail appropriate for a SAP is excessive for a protocol. However, there is no detailed guidance on the content of a SAP and consequently, there is marked variation in practice.
Secondary analysis of clinical trial data reveals dengue burden